InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Moxie Dwight, Vice-Président Senior, Avocat Général et Secrétaire. Insider active across 1 company, notably Revance Therapeutics, Inc.. Aggregated, 13 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €737k. History available since 27 September 2021. The latest transaction was filed on 4 February 2025 (U). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Moxie Dwight
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
47,815 shares@ US$3.6513.9% of flowCommon StockSEC:0000950170-25-015361:0
5,979 shares0Common StockSEC:0000950170-25-014823:0
3,269 shares@ US$5.3051.3% of flowCommon StockSEC:0001479290-24-000067:0
15,143 shares0Common StockSEC:0001479290-24-000053:0
90,000 shares0Common StockSEC:0001479290-24-000016:0
23,853 shares@ US$17.814132.6% of flowCommon StockSEC:0001479290-23-000102:0
19,346 shares0Common StockSEC:0001479290-23-000098:0
42,349 shares0Common StockSEC:0001479290-23-000076:0
7,330 shares@ US$30.6517.2% of flowCommon StockSEC:0001479290-23-000040:0
42,349 shares0Common StockSEC:0001479290-23-000037:0
11,000 shares@ US$27.072524.5% of flowCommon StockSEC:0001479290-22-000086:0
2,881 shares@ US$15.793.5% of flowCommon StockSEC:0001209191-22-019721:0
1,675 shares@ US$30.003.7% of flowCommon StockSEC:0001479290-21-000154:0
13 of 13 declarations
About Moxie Dwight
Moxie Dwight is Senior Vice President, General Counsel and Secretary at Revance Therapeutics, Inc. (XNAS). The declarant has 13 filings in total, and across the 13 recent sampled filings between 2021-09-28 and 2025-02-06, sales total EUR 737387 and the most frequent transaction nature is Attribution.
